Arkolith/Insider Trading/LBRX/Form 4

Eramo Anna

Chief Medical OfficerLB PHARMACEUTICALS INC (LBRX) · full profile →Form 4 · filed Sep 12, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
0 non-derivative · 5 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 10, 2025Disposed to issuer(D)6K——0
Sep 10, 2025Grant(A)27K——27K
Sep 10, 2025Disposed to issuer(D)27K——0
Sep 10, 2025Grant(A)6K——6K
Sep 10, 2025Grant(A)156K—$0156K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-024444) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML